Release Date: Nov 26, 2016
Valid Through: Nov 26, 2018. This course will be updated or expired on this date
Successful Completion: Complete entire module, complete the exam with a passing score of 80% or better, and complete the evaluation form
Estimated Time to Complete Activity: 60 minutes
CEUs: See Continuing Education section
Media: Internet. Available 24/7 365 Online. See requirements below
By the end of this self-study, educational module, the user should: Be able to define “bloodborne pathogen” Be able to identify methods of bloodborne pathogen transmission and prevention Have an understanding of Hepatitis B, Hepatitis C and HIV infection Explain the concepts of Universal Precautions and Standard Precautions Be familiar with OSHA’s Bloodborne Pathogen Standard Understand the purpose of personal protective equipment Understand the concepts of work practice and engineering controls Know what to do if he/she is exposed to blood or OPIM
Commonly referred to as: Bloodborne Pathogens and Bloodborne Pathogens Safety
Whenever an individual comes into contact with another person’s blood or certain body fluids, there is a potential exposure to a bloodborne pathogen
Two government agencies, the Occupational Safety and Health Administration (OSHA) and the Center for Disease Control (CDC) have created regulations and recommendations to reduce this exposure, especially within the workplace
Anyone who may anticipate coming into contact with blood or body fluids as part of their job should be aware of what bloodborne pathogens are, how they are transmitted, how they can protect themselves and their employer’s responsibility to provide a safe working environment
HIPAA Exams, Inc. requires that the faculty participating in any activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this activity. HIPAA Exams, Inc. also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a activity.
This activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products.
The content for this activity was developed independently of the commercial support. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ANCC Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
|Bundle||Price Per Person|
|100 +||Call for $|
Toll Free: 1.888-362-2288
9 AM - 5 PM MST (M-F)